Changes in serum levels of myokines and WNT-antagonists after an ultramarathon race

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Kerschan Schindl, Katharina ^a   Thalmann, Markus M ^b   Weiss, Elisabeth ^c   Tsironi, Maria ^d   Föger Samwald, Ursula ^c   Meinhart, Johann ^b   Skenderi, Katerina ^e   Pietschmann, Peter ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Cardiovascular Surgery Hospital Hietzing ^*  (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF PELOPONNESE   (Greece)

^e HAROKOPIO UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; CYTOKINE; DICKKOPF 1 PROTEIN; FOLLISTATIN; MYOKINE; MYOSTATIN; SCLEROSTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; CTSK PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; FST PROTEIN, HUMAN; GENETIC MARKER; MSTN PROTEIN, HUMAN; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE; SIGNAL PEPTIDE; SOST PROTEIN, HUMAN;

ADULT; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MARATHON RUNNER; NORMAL HUMAN; PROTEIN BLOOD LEVEL; VENOUS BLOOD; WNT SIGNALING PATHWAY; BLOOD; ETIOLOGY; GENETIC MARKER; METABOLISM; MIDDLE AGED; OSTEOLYSIS; PHYSIOLOGY; RUNNING; SKELETAL MUSCLE;

ELAGATIS;

ADULT; BIOMARKERS; BONE MORPHOGENETIC PROTEINS; BONE RESORPTION; CATHEPSIN K; COLLAGEN TYPE I; FEMALE; FOLLISTATIN; GENETIC MARKERS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSTATIN; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; RUNNING; WNT SIGNALING PATHWAY;

EID: 84940056626     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0132478     Document Type: Article

References (39)

1. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TNF-ß superfamily member. Nature 1997; 387: 83-90. PMID: 9139826.
2. Ma K, Mallidis C, Bhasin S, Mahabadi V, Artaza J, Gonzalez-Cadavid N, et al. Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. Am J Physiol Endorcinol Metab 2003; 285: E363-E371.
3. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296: 1486-1488. PMID: 12029139.
4. Zhu X, Topouzis S, Liang LF, Stotish RL. Myostatin signaling through Smad3, Smad3, and Smad4 is regulated by the inhibitor y Smad7 by negative feedback mechanism. Cytokine 2004; 26: 262-272. PMID: 15183844.
5. Ke HZ, Richards WG, Li X, Ominsky MS. Sclerostin and Dickkopf-1 as therapeutic targets in bone disease. Endocrine Reviews 2012; 33: 747-783. doi:10.1210/er.2011-1060 PMID: 22723594.
6. Costa A, Cusano E, Silva BC, Cremers S, Bilezikian JP. Cathepsin K: Its skeletal actions and role as a therapeutic target in osteoporosis. Nature Reviews Rheumatology 2011; 7: 447-456. doi:10.1038/nrrheum.2011.77 PMID: 21670768.
7. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: Focus on muscle-derived interleukin-6. Physiol Rev; 88: 1379-1406. doi:10.1152/physrev.90100.2007 PMID: 18923185.
8. Allen D, Hittel DS, McPherron AC. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc 2011; 43: 1828-1835. doi:10.1249/MSS.0b013e3182178bb4 PMID: 21364474.
9. Kerschan-Schindl K, Thalmann M, Sodeck GH, Skenderi K, Matalas AL, Grampp S, et al. A 246-km continuous running race causes significant changes in bone metabolism. Bone 2009; 45: 1079-1083. doi:10.1016/j.bone.2009.07.088 PMID: 19665602.
10. Goussetis E, Spiropoulos A, Tsironi M, Skenderi K, Margeli A, Graphakos S, et al. Spartathlon, a 246 kilometer foot race: Effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells. Blood Cells Mol Dis 2009; 42: 294-299. doi:10.1016/j.bcmd.2009.01.003 PMID: 19233694.
11. Margeli A, Skenderi K, Tsironi M, Hantzi E, Matalas AL, Vrettou C, et al. Dramatic elevations of interleukin- 6 and acute-phase reactanta in athlets participating in the ultradistance foot race Spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. J Clin Endocrinol & Metab 2005; 90: 3914-3918.
12. Papassotiriou I, Alexiou VG, Tsironi M, Skenderi K, Spanos A, Falagas ME. Severe aseptic inflammation caused by long distance running (246 km) does not increase procalcitonin. Eur J Clin Invest 2008; 38: 276-279. doi:10.1111/j.1365-2362.2008.01935.x PMID: 18339008.
13. Jeukendrup AE, Vet-Joop K, Sturk A, Stegen JH, Senden J, Saris JW, et al. Relationship between gastro- intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci 2000; 98: 47-55. PMID: 10600658.
14. Pinho RA, Silva LA, Pinho CA, Scheffer DL, Souza CT, Benetti M, Carvalho T, Dal-Pizzol F. Oxidative stress and inflammatory parameters after an Ironman race. Clin J Sports Med 2010; 20: 306-311.
15. Skenderi KP, Kavouras SA, Anastasiou CA, Yiannakouris N, Matalas AL. Exertional rhabdomyolysis during a 246-km continuous running race. Med Sci Sports Exerc 2006; 38: 1054-1057. PMID: 16775544.
16. Schiffer T, Geisler S, Sperlich B, Strüder HK. MSTN mRNA after varying exercise modalities in humans. Int J Sports Med 2011; 32: 683-687. doi:10.1055/s-0031-1279732 PMID: 21695666.
17. Willoughby DS, Taylor L. Effects of concentric and eccentric muscle actions on serum myostatin and follistatin-like related gene levels. J Sports Med 2004; 3: 226-233.
18. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc 2004; 36: 574-582. PMID: 15064583.
19. Walker KS, Kambadur R, Sharma M, Smith HK. Resistance training alters plasmy myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc 2004; 36: 787-793. PMID: 15126711.
20. Hulmi JJ, Ahtiainen JP, Kaasalainen T, Pöllänen E, Häkkinen K, Alen M, et al. Postexercise myostatin and activin IIb mRNA levels: Effects of strength training. Med Sci Sports Exerc 2007; 39: 289-297. PMID: 17277593.
21. Pereira BC, Pauli JR, de Souza CT, Ropelle ER, Cintra DE, Rocha EM, et al. Nonfunctional overreaching leads to inflammation and myostatin upregulation in swiss mice. Int J Sports Med 2014; 35: 139- 146. doi:10.1055/s-0033-1349077 PMID: 23868687.
22. Ochi E, Nakazato Km Ishii N. Muscular hypertrophy and changes in cytokine production after eccentric training in the rat skeletal muscle. J Strength Cond Res 2011; 25: 2283-2292. doi:10.1519/JSC.0b013e3181f1592e PMID: 21606857.
23. Hansen J, Brandt C, Nielsen AR, Hojman P, Whitham M, Febbraio MA, et al. Exercise induces a markes increase in plasma follistatin: Evidence that follistatin is a contraction-induced hepatokine. Endocrinology 2011; 152: 164-171. doi:10.1210/en.2010-0868 PMID: 21068158.
24. Görgens SW, Raschke S, Holven KB, Jensen J, Eckhardt K, Eckel J. Regulation of follistatin-like protein1 expression and secretion in primary human skeletal muscle cells. Arch Physiol Biochem 2013; 119: 75-80. doi:10.3109/13813455.2013.768270 PMID: 23419164.
25. Jensky NE, Sims JK, Rice JC, Dreyer HC, Schroeder ET. The influence of eccentric exercise on mRNA expression of skeletal muscle regulators. Eur J Appl Physiol 2007; 101: 473-480. PMID: 17661068.
26. Dalbo VJ, Roberts MD, Sunderland KL, Poole CN, Stout JR, Beck TW, et al. Acute loading and aging effects on myostatin pathway biomarkers in human skeletal muscle after three sequential bouts of resistance training. J Gerontol A Biol Sci Med Sci 2011; 66A: 855-865.
27. Dalbo VJ, Roberts MD, Hassel S, Kerksick CM. Effects of pre-exercise feeding on serum hormone concentrations and biomarkers of myostatin and ubiquitin proteasome pathway activity. Eur J Nutr 2013; 52: 477-487. doi:10.1007/s00394-012-0349-x PMID: 22476926.
28. Ardawi MS, Rouzi AA, Quari MH. Physical activity in relation to serum sclerostin, indulin-like growth factor- 1, and bone turnover markers in healthy premenopausal wome: A cross-sectional and longitudinal study. J Clin Endocrinol Metab 2012; 97: 3691-3699. doi:10.1210/jc.2011-3361 PMID: 22865898.
29. Amrein K, Amrein S, Drexler C Dimai HP, Dobnig H, Pfeifer K, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 2012; 97: 148-154. doi:10.1210/jc.2011-2152 PMID: 21994959.
30. Fazeli PK, Ackerman KE, Pierce L, Guereca G, Bouxsein M, Misra M. Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes. Osteoporos Int 2013; 24: 2433-2440. doi:10.1007/s00198-013-2353-2 PMID: 23579340.
31. Bergström I, Parini P, Gustafsson SA, Andersson G, Brinck J. Physical training increases osteoprotegerin in postmenopausal women. J Bone Miner Res 2012; 30: 202-207.
32. Bayod S, Menella I, Sanchez-Roige S, Lalanza JF, Escorihuela RM, Camins A, et al. Wnt pathway regulation by long-term moderate exercise in rat hippocampus. Brain Res 2014; 1543: 38-48. doi:10.1016/j.brainres.2013.10.048 PMID: 24183784.
33. Malm HT, Ronni-Sivula HM, Viinikka LU, Ylikorkala OR. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels. Calcif Tissue Int 1993; 52: 209-211. PMID: 8481834.
34. Crespo R, Revilla M, Villa LF, Usabiaga J, Leibar X, Rico H. Transient dissociation of bone metabolism induced by high performance exercise: A study in elite marathon runners. Calcif Tissue Int 1999; 64: 287-290. PMID: 10089219.
35. Mouzopoulos G, Stamatakos M, Tzurbakis M, Tsembeli A, Manti C, Safioleas M, et al. Changes of bone turnover markers after marathon running over 245 km. Int J Sports Med 2007; 28: 576-579. PMID: 17436198.
36. Sipos W, Rauner M, Skalicky M, Viidik A, Hofbauer G, Schett G, et al. Running as a negative effect on bone metabolism and proinflammatory status in male aged rats. Exp Gerontol 2008; 43: 578-583. doi:10.1016/j.exger.2008.03.008 PMID: 18442888.
37. Hind K, Truscott JG, Evans JA. Low lumbar spine bone mineral density in both male and female endurance runners. Bone 2006; 39: 880-885. PMID: 16682267.
38. Drysdale IP, Collins AL, Walters NJ, Bird D, Hinkley HJ. Potential benefits of marathon training on bone health as assessed by calcaneal broadband ultrasound attenuation. J Clin Densitom 2007; 10: 179- 183. PMID: 17485036.
39. Wilks DC, Winwood K, Gilliver SF, Kwiet A, Chatfield M, Michaelis I, et al. Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runers, race-walkers and sedentary control participants: A pQCT study. Bone 2009; 45: 91-97. doi:10.1016/j.bone.2009.03.660 PMID: 19332164.